WeRide granted waiver for founders’ family trust transfers
WeRide Inc. reports that The Stock Exchange of Hong Kong Limited has granted a waiver from strict compliance with Rule 8A.18(1) of the Listing Rules.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
WeRide Inc. reports that The Stock Exchange of Hong Kong Limited has granted a waiver from strict compliance with Rule 8A.18(1) of the Listing Rules. The waiver facilitates intra‑group share allotments and issuances by two British Virgin Islands entities, Xu Han Limited and Humber Partners Limited, into family trust structures for founders Dr. Tony Xu Han and Dr. Yan Li.
After these transactions, Xu Han Limited is owned 80% by Dr. Han and 20% by the trustee of his family trust, while Humber Partners is owned 80% by Dr. Li and 20% by the trustee of his family trust. Dr. Han and Dr. Li each remain protector of his respective family trust and retain sole control over the voting rights attached to the class B ordinary shares held within these structures, preserving the existing weighted voting rights framework.
Filing Explained
The waiver enables trust restructurings while the filing discloses no new WeRide shares or change in existing holders’ percentage ownership.
The
The waiver facilitates planned share issuances by two companies holding WeRide shares to family-trust trustees; it does not disclose a completed change to WeRide’s share count or existing holders’ percentage ownership.
Under the disclosed structure, XHL and Humber Partners would each issue new shares so that the relevant founder retains
The filing records the waiver as granted, but does not state that the two entity-level allotments have been completed or provide a completion date.
Key Figures
Key Terms
weighted voting rights regulatory
Rule 8A.18(1) regulatory
family trust financial
WVR Beneficiary regulatory
protector financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did WeRide Inc. (WRD) disclose in this July 2026 report?
What is the purpose of the waiver granted to WeRide Inc. (WRD)?
How did ownership of Xu Han Limited change according to WeRide (WRD)?
How did ownership of Humber Partners Limited change for WeRide (WRD)?
Does the WeRide (WRD) waiver affect its weighted voting rights structure?
Who are the weighted voting rights beneficiaries at WeRide Inc. (WRD)?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number: 001-42213
WeRide Inc.
21st Floor, Tower A, Guanzhou Life Science Innovation Center
No. 51, Luoxuan Road, Guangzhou International Biotech Island
Guangzhou 510005
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 99.1 | Announcement - Grant of Waiver from Strict Compliance with Rule 8A.18(1) of the Listing Rules, dated July 13, 2026 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| WeRide Inc. | ||
| By: | /s/ Jennifer Li | |
| Name: | Jennifer Li | |
| Title: | Chief Financial Officer | |
Date: July 13, 2026
Exhibit 99.1
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
WeRide Inc.
文遠知行*
(A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability)
(Stock code: 0800)
GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 8A.18(1) OF THE LISTING RULES
WeRide Inc. (the “Company”) hereby advises shareholders and other investors that it has applied for, and The Stock Exchange of Hong Kong Limited has granted, a waiver (the “Waiver”) from strict compliance with Rule 8A.18(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited to facilitate (i) the allotment and issuance of new shares by Xu Han Limited (“XHL”), a British Virgin Islands company wholly owned by Dr. Tony Xu Han (“Dr. Han”), the founder, chairman of the board, executive director, chief executive officer and a beneficiary of weighted voting rights of the Company (a “WVR Beneficiary”), that holds class B ordinary shares of the Company to the trustee of a family trust where Dr. Han is the protector and his children and descendants are the beneficiaries; and (ii) the allotment and issuance of new shares by Humber Partners Limited (“Humber Partners”), a British Virgin Islands company wholly owned by Dr. Yan Li (“Dr. Li”), the co-founder, executive director, chief technology officer and a WVR Beneficiary of the Company, that holds class A ordinary shares and class B ordinary shares of the Company to the trustee of a family trust where Dr. Li is the protector and his children and descendants are the beneficiaries. Following the aforementioned share allotment and issuance, XHL is owned as to 80% by Dr. Han and as to 20% by the trustee of Dr. Han’s family trust, and Humber Partners is owned as to 80% by Dr. Li and as to 20% by the trustee of Dr. Li’s family trust. The Company applied for the Waiver, and the Waiver was granted, on the bases, among others, that each of Dr. Han and Dr. Li will remain the protector of his family trust and will retain sole control over the voting rights attached to the class B ordinary shares of the Company held within his family trust structure following the aforementioned share allotment and issuance.
| By Order of the Board | |
| WeRide Inc. | |
| Dr. Tony Xu Han | |
| Chairman of the Board, Executive Director and Chief Executive Officer |
Hong Kong, July 13, 2026
As of the date of this announcement, the board of directors of the Company comprises Dr. Tony Xu Han and Dr. Yan Li as executive directors, Mr. Ichijo Futakawa and Mr. Jean-François Salles as non-executive directors, and Ms. Huiping Yan, Mr. David Zhang and Dr. Tony Fan-cheong Chan as independent non-executive directors.
| * | For identification purposes only |